IP Library Assignment 044732/0044
Patent Assignment
Reel/Frame 044732/0044

Assignment of Assignor's Interest

Recorded: 2018-01-25 Pages: 10
Assignors
DEROSA, FRANK
Executed: 2018-01-23
HEARTLEIN, MICHAEL
Executed: 2018-01-23
SMITH, LIANNE
Executed: 2018-01-23
KARVE, SHRIRANG
Executed: 2018-01-23
Assignee
TRANSLATE BIO MA, INC.
200 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency
Application: 15/621,616 →
Publication: US 2018/0008680
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 2, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 044353/0922 →
Change of Name Nov 2, 2017
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 044354/0009 →
Assignment of Assignor's Interest Nov 2, 2017
From: HEARTLEIN, MICHAEL; DEROSA, FRANK; SMITH, LIANNE
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 044019/0252 →
Assignment of Assignor's Interest Sep 3, 2020
From: TRANSLATE BIO MA, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 053685/0346 →